TOKYO: Japan has approved a new antiviral procedure to treat patients infected with the code 19 virus.
According to foreign media reports, Japan has approved GlaxoSmithKline and Vera Biotechnology’s Sutra Wemab V as an antibody treatment for the corona virus, as well as Sutra Wemab V for the fifth time in Japan for the treatment of Code Nineteen. Has become a medicine.
According to media reports, the announcement was made by Japanese Health Minister Norihisa Tamura. There will be mild symptoms and they will not need oxygen supplementation.
It should be noted that Sutro Weimab has received the approval of the European Commission on Human Medicine, after which it has been given temporary permission to use in Canada, Italy, Singapore, United Arab Emirates and other countries.
